A patient with pulmonary lymphangitic carcinomatosis successfully treated with TS-1 and cisplatin

Internal Medicine

Volumn 46, Issue 8, 2007, Pages 491-494

  Kikuchi, Norihiro ^a   Shiozawa, Toshihiro ^a   Ishii, Yukio ^a   Satoh, Hiroaki ^a   Noguchi, Masayuki ^a   Ohtsuka, Morio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cancer of unknown primary; Chemotherapy; Pulmonary lymphangitic carcinomatosis; TS 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; TS 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; BRAIN METASTASIS; BRAIN SCINTISCANNING; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DERMATITIS; DYSPNEA; FATALITY; FATIGUE; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG BLOOD VESSEL; LUNG CARCINOMA; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; SURVIVAL TIME; THORAX RADIOGRAPHY; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; UNSPECIFIED SIDE EFFECT;

ADULT; CARCINOMA; CISPLATIN; DRUG THERAPY, COMBINATION; HUMANS; LUNG NEOPLASMS; MALE; SILICATES; TITANIUM;

EID: 34247359616     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6363     Document Type: Article

References (17)

1. Greco FA, Burris HA 3rd, Erland JB, et al. Carcinoma of unknown primary site. Cancer 89: 2655-2660, 2000.
2. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 39: 1990-2005, 2003.
3. Yang SP, Lin CC. Lymphangitic carcinomatosis of the lungs. The clinical significance of its roentogenologic classification. Chest 62: 179-187, 1972.
4. Heinzman ER, Neoplasms of the lung, airways and pleura. The Lung: Radiologic-Pathologic Correlatons. 2nd ed. CV Mosby, St. Louis, 1984: 413-421.
5. Sadoff L, Grossman J, Weiner N. Lymphangitic pulmonary metastasis secondary to breast cancer with normal chest X-rays and abnormal perfusion lung scans. Oncology 31: 164-171, 1975.
6. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review. Bethesda. National Cancer Institute, 1999.
7. Levi F, Te VC, Erler G, Randimbison L, La Vecchia C. Epidemiology of unknown primary tumors. Eur J Cancer 38: 1810-1812, 2002.
8. van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW, Hillen HF. Epidemiology of unknown primary tumors; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer 38: 409-413, 2002
9. Greco FA, Hainsworth JD. Tumors of unknown origin. CA Cancer J Clin 42: 96-115, 1992.
10. Saghatchian M, Fizazi K, Borel C, et al. Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation-results of a prospective study. Ann oncol 12: 535-540, 2001.
11. Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 13: 2094-2103, 1995.
12. Pavlidis N, Kosmidis P, Skarlos D, et al. Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study. Ann Oncol 3: 631-634, 1992.
13. Greco FA, Burris HA 3rd, Erland EB, et al. Carcinoma of unknown primary site. Long term follow-up after treatment with paclitaxel, carboplatin and etoposide. Cancer 89: 2655-2660, 2000.
14. Briasoulis E, Kalofonos H, Bafaloukos D, et al. Carboplatin plus paclitaxel in unknown primary carcinoma; a phase II Hellenic Cooperative Oncology Group Study. J Clin Oncol 18: 3101-3117, 2000.
15. Kawahara M, Furuse K, Segawa Y, et al. S-1 Cooperative Study Group (Lung Cancer Working Group). Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer. Br J Cancer 85: 939-934, 2001.
16. Baba H, Yamamoto M, Endo K, et al. Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer. Gastric Cancer 6 (suppl 1): 45-49, 2003.
17. Ichinose Y, Yoshimori K, Sakai H, et al. S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: A multi-institutinal phse II trial. Clin Cancer Res 10: 7860-7864, 2004.